CNET editor Gael Fashingbauer Cooper, a journalist and pop-culture junkie, is co-author of "Whatever Happened to Pudding Pops? The Lost Toys, Tastes and Trends of the '70s and '80s," as well as "The ...

CNET editor Gael Fashingbauer Cooper, a journalist and pop-culture junkie, is co-author of "Whatever Happened to Pudding Pops? The Lost Toys, Tastes and Trends of the '70s and '80s," as well as "The ...

Forbes contributors publish independent expert analyses and insights. Kris Holt is a writer who covers video games and word games. This voice experience is generated by AI. Learn more. This voice ...

WASHINGTON, April 23 (Reuters) - The Trump administration has approved only one Gold Card visa under a program granting U.S. residency to non-citizens for a $1 million fee, ‌Commerce Secretary Howard ...

A program in Colorado is shaping the next generation of builders, designers, and engineers. The ACE Mentor program gives high school students real-world insight into careers in construction. Seniors ...

Medicare has delayed a program for older Americans that would've required participating insurance companies to cover GLP-1 weight loss drugs such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound.

Amazon is rolling out a new GLP‑1 program aimed at simplifying access to popular weight-loss drugs, from doctor visits to prescription delivery. The company announced on April 21 that Amazon One ...

Customers will be able to compare insurance and cash-pay prices at checkout, with manufacturer coupons automatically applied to those eligible. (iStock / Getty Images Plus) Amazon One Medical has ...

Amazon One Medical launched a GLP-1 program integrating obesity care with Amazon Pharmacy. Pricing for the popular weight loss drugs will begin at as low as $25 per month with insurance. Shares of ...

HONG KONG--(BUSINESS WIRE)--MetLife Foundation announced new recipients of its Community Impact Grant Program (CIGP), providing more than $6.5 million to global nonprofit organizations, including 26 ...

The biggest stories of the day delivered to your inbox.

The maker of the GLP-1 weight-loss drug Wegovy is promising “a lower, predictable monthly price” for patients who use a new subscription program for the medication. The savings add up to $600 a year ...